Division of Molecular Pathology

Laboratories in the Division

The Laboratories in the Division of Molecular Pathology offer state-of-the-art clinical molecular testing for leukemia, lymphoma, and solid tumors. Founded in 1986, the laboratories have three decades of experience in the field of molecular diagnostics of cancer.

The Molecular Diagnostics Lab is a CLIA and CAP-certified lab offering DNA and RNA based assays for solid tumors and hematologic malignancies. Currently, the lab performs over 6,000 tests a year, mostly for cancer patients. Our tests range from simple PCR amplifications to complex tests translated from cutting-edge research findings to clinical utility. In January 2013, the lab began to provide next generation sequencing panels, and this is the most rapidly expanding function of the lab. The goal is to offer whole exome sequencing and/or whole genome sequencing for cancer patients in the future.

The Cytogenetics Lab offers karyotype analysis and SNP-microarray analysis to detect balanced, unbalanced, and copy number neutral chromosome abnormalities at the whole genome level. The lab also performs fluorescence in-situ hybridization (FISH) analysis to detect targeted chromosome abnormalities. The results from these studies play important roles in cytogenetic diagnosis, prognosis, and guide treatment of specific types of hematologic malignancies and solid tumors.

» Molecular Diagnostics Laboratory

» Cytogenetics Laboratory

Division Administrative Staff:

Molecular Genetic Pathology Fellowship

A one-year fellowship program designed to train individual for academic careers in molecular diagnostics and research is available. For details on the fellowship program and application instructions, see: Molecular Genetic Pathology Fellowship